[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BagelC47 [@BagelC47](/creator/twitter/BagelC47) on x XXX followers Created: 2025-07-12 18:01:23 UTC $DAWN DAY301 is designed to overcome many of the limitations of earlier ADCs that targeted PTK7, such as toxicity, limited penetration, and drug resistance. Its features — from a stable, cleavable linker to a high DAR and broad bystander killing potential — all point to a well-engineered molecule with strong therapeutic promise. If early clinical data reflect the preclinical success, DAY301 could become a first-in-class ADC with meaningful impact across several hard-to-treat cancers.  XXXXX engagements  **Related Topics** [$dawn](/topic/$dawn) [dawn protocol](/topic/dawn-protocol) [coins defi](/topic/coins-defi) [coins nft](/topic/coins-nft) [Post Link](https://x.com/BagelC47/status/1944094754842849445)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BagelC47 @BagelC47 on x XXX followers
Created: 2025-07-12 18:01:23 UTC
$DAWN DAY301 is designed to overcome many of the limitations of earlier ADCs that targeted PTK7, such as toxicity, limited penetration, and drug resistance. Its features — from a stable, cleavable linker to a high DAR and broad bystander killing potential — all point to a well-engineered molecule with strong therapeutic promise. If early clinical data reflect the preclinical success, DAY301 could become a first-in-class ADC with meaningful impact across several hard-to-treat cancers.
XXXXX engagements
Related Topics $dawn dawn protocol coins defi coins nft